Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are looking forward to welcoming Dr Ben Seymour to our Wellcome Centre for Integrative Neuroimaging.

Dr Seymour has received a Senior Research Fellowship in Clinical Science on ‘Neural mechanisms of endogenous analgesia’. His appointment is a joint one between the Nuffield Department of Clinical Neurosciences and the Oxford Institute for Biomedical Engineering and will start on 1 April 2020.

'I am excited to join so many young and creative colleagues working in Oxford, especially with respect to the existing strengths in pain and computational neuroscience. I'm looking forward to developing many new collaborations across the clinical and engineering spectrum'.
- Ben Seymour

BenSeymour.jpgBen's work addresses the computational and systems neuroscience of pain. This research is part theoretical: building realistic models of neuronal information processes to understand processes of pain perception and behaviour, and part experimental: testing these theories using a range of experimental methodologies, especially fMRI.

A particular focus of his research is on endogenous analgesia: understanding why pain is modulated by so many factors, and how this helps the pain system optimise protection against arm. Ultimately, this research aims to develop new technology-based therapies for treating pain in clinical populations.

Similar stories

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

COVID-19 infection has greater risk than vaccines of causing very rare neurological events

Research reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between a core team of Professors Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Dr Mark Howe at Boston University and Professor Dinos Meletis at the Karolinska Institute, as well as collaborators Professor Yulong Li at Peking University and Dr Michael Lin at Stanford University.

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.

Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd

Mapping brain network activity from structural connectivity using deep learning

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.